Lys Therapeutics

Pharmaceutical Manufacturing • Lyon, Auvergne-Rhône-Alpes, France • 11-20 Employees

Company overview

Headquarters	56, Rue Saint-Jean-de-Dieu, Lyon, Auvergne-Rhône-Alpes 69007, FR
Website	lystherapeutics.com
NAICS	3254
Keywords	Biotechnology, Healthcare, Pharma, Neurology, Drug Development, Multiple Sclerosis, Antibody, Neurosciences, Stroke, CNS, Parkinson, Parkinson'S Disease, Neurodegenerative Disorders, Neurovascular Diseases
Founded	2021
Employees	11-20
Socials

Key Contact at Lys Therapeutics

Thibault Honegger

Co-Founder & Board Member

Lys Therapeutics Email Formats

Lys Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@lystherapeutics.com), used 77.8% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@lystherapeutics.com	77.8%
{first initial}{last name}	jdoe@lystherapeutics.com	22.2%

About Lys Therapeutics

Lys Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies to treat patients suffering from neurodegenerative and neurovascular diseases with high unmet medical needs. Its lead candidate, LYS241, is a vascular-targeting immunotherapy with a unique mode of action restoring BBB integrity by blocking the pathological interaction between tPA and vascular NMDA receptors. This mechanism is central to the pathogenesis of several major neurological disorders, including Parkinson’s disease, ischemic stroke, and multiple sclerosis. With operations in Lyon and Caen (France), and strategic collaborations with international research institutions, Lys Therapeutics is advancing a robust and versatile pipeline, supported by prestigious funding partners including The Michael J. Fox Foundation, Bpifrance, and private investors. Lys Therapeutics' approach of targeting neuroinflammation to combat neurodegeneration represents a promising avenue in the search for effective treatments for these debilitating disorders. More information on lystherapeutics.com

Lys Therapeutics revenue & valuation

Annual revenue	$1,197,770
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$3,900,000
Total funding	$600,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Lys Therapeutics has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Lys Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-04-15	9	$600,000
2023-06-15	13	N/A

Funding Insights

$600,000

Total funding amount

Number of funding rounds

Lys Therapeutics Tech Stack

Discover the technologies and tools that power Lys Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Microsoft Word

Editors

Varnish

Caching

Lightbox

JavaScript libraries

PHP

Programming languages

Open Graph

Miscellaneous

WordPress

Blogs

jQuery Migrate

JavaScript libraries

Google Analytics

Analytics

Frequently asked questions

Lys Therapeutics is located in Lyon, Auvergne-Rhône-Alpes, FR.

Lys Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Lys Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Lys Therapeutics has raised a total of $600,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Lys Therapeutics

Thibault Honegger

Co-Founder & Board Member

4.8

40,000 users